Cup a 1 clinical trials

Multicenter, double-blind, randomized, placebo-controlled phase III clinical trial in parallel groups which evaluates the clinical efficacy and safety of immunotherapy with the purified major allergen Cup a 1, in patients with moderate/severe allergic rhino conjunctivitis with or without controlled asthma, sensitized to Cupressaceae

This study is testing a new treatment for people with moderate to severe hay fever caused by cypress tree pollen. It aims to see if a special type of immunotherapy, using a purified allergen called Cup a 1, can reduce symptoms and improve quality of life.